MET and kidney cancer: The findings suggest that genes associated with kidney cancer, including VHL, MET, FH, FLCN, TSC1, TSC2, and SDH, are involved in metabolic pathways linked to oxygen and iron or nutrient sensing, thus characterizing kidney cancer as a cellular metabolic disease (Linehan et al., 2010).